If you have advancedovarian cancer, it means that yourcancerhas spread outside of your ovary into other areas of your body. As a result, your symptoms may be harder to manage than before it spread. Whichever ones you have, there are many ways you and your doctor can work together to he...
OBJECTIVE: This study sought to develop and examine preliminary validity of the NCCN-FACT Ovarian Symptom Index-18 (NFOSI-18), a new ovarian cancer-specific symptom index comprised of symptoms rated as highest priority by both oncology clinical experts and women with advanced ovarian cancer. ...
Some people who have ovarian cancer and who have received previous treatment with chemotherapy or certain other medicines for their cancer have developed MDS or AML during treatment with ZEJULA. MDS or AML may lead to death. Symptoms of low blood cell counts (low red blood cells, low white bl...
For the majority of patients, however, the goals of treatment focus on palliation of symptoms and patient QOL.3 Numerous effective agents can be used in this setting. The factor that most Summary MOST patients with advanced ovarian cancer experience side effects with chemotherapy that adversely ...
A study investigated the effects of the increased adoption of neoadjuvant chemotherapy in patients with advanced ovarian cancer. Ovarian cancer is the fourth leading cause of cancer deaths among American women, demonstrating how aggressive it might be.
9 The QLQ-OV28 contains 28 items relevant to ovarian cancer, including abdominal or gastrointestinal symptoms, peripheral neuropathy, chemotherapy side effects, hormonal or menopausal symptoms, body image, attitude to disease or treatment, and sexual functioning.11 Questionnaires were completed at ...
We believe that the delay of important symptoms, such as those associated with ascites or bowel occlusion, is an important goal of the treatment of recurrent ovarian cancer. In patients with asymptomatic CA125 increase, more effective therapies able to improve survival are needed and these patients...
The absence of CYP2E1 gene in mice that were fed with a high-fat diet did not show NASH symptoms and were also protected from hepatic metabolic alterations in Glut-1, Glut-4, phosphofructokinase and phosphoenolpyruvate carboxykinase gene expressions (involved in carbohydrate metabolism), and UCP-...
Women with advanced ovarian cancer have fewer side effects and tend to have a better quality of life if given chemotherapy before surgery, according to a Cancer Research UK study published today (Wednesday) in The Lancet.
In fact, it can help to identify patients who should undergo radiology in order to select those that can benefit from surgery or from early treatment before the onset of symptoms, which are usually related to an excessive disease burden. The delay of disease symptoms, such as those associated...